BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30797271)

  • 1. Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
    Soedarsono S; Subiantoro MC
    Indian J Tuberc; 2019 Jan; 66(1):134-138. PubMed ID: 30797271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.
    Xu L; Cui G; Jia H; Zhu Y; Ding Y; Chen J; Lu C; Ye P; Gao H; Li L; Ma W; Lyu J; Diao H
    J Transl Med; 2016 Jun; 14(1):179. PubMed ID: 27311307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.
    Kang HK; Jeong BH; Lee H; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Koh WJ
    Medicine (Baltimore); 2016 Aug; 95(31):e4540. PubMed ID: 27495111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment.
    Chang CY; Hong JY; Yuan MK; Chang SJ; Lee YM; Chang SC; Hsu LC; Cheng SL
    Drug Des Devel Ther; 2013; 7():53-8. PubMed ID: 23386785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis.
    Lee HY; Chae KO; Lee CH; Choi SM; Lee J; Park YS; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ
    PLoS One; 2014; 9(8):e103768. PubMed ID: 25105410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M; Abraham N; Beery M; Williams S; Smit S; Uys M; Reddy C; Medina-Marino A
    BMC Infect Dis; 2016 Aug; 16():365. PubMed ID: 27484399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania.
    Nagu TJ; Spiegelman D; Hertzmark E; Aboud S; Makani J; Matee MI; Fawzi W; Mugusi F
    PLoS One; 2014; 9(3):e91229. PubMed ID: 24642636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring treatment responses in patients with pulmonary TB using serial lung gallium-67 scintigraphy.
    Liu SF; Liu JW; Lin MC; Lee CH; Huang HH; Lai YF
    AJR Am J Roentgenol; 2007 May; 188(5):W403-8. PubMed ID: 17449733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained elevated levels of C-reactive protein and ferritin in pulmonary tuberculosis patients remaining culture positive upon treatment initiation.
    Miranda P; Gil-Santana L; Oliveira MG; Mesquita ED; Silva E; Rauwerdink A; Cobelens F; Oliveira MM; Andrade BB; Kritski A
    PLoS One; 2017; 12(4):e0175278. PubMed ID: 28384354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of CA-125 in pulmonary tuberculosis.
    Kim ES; Park KU; Song J; Lim HJ; Cho YJ; Yoon H; Lee J; Lee CT; Park JS
    Tuberculosis (Edinb); 2013 Mar; 93(2):222-6. PubMed ID: 23414674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
    Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
    Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
    Azam K; Khosa C; Viegas S; Massango I; Bhatt N; Jani I; Heinrich N; Hoelscher M; Gillespie SH; Rachow A; Sabiiti W
    Front Immunol; 2022; 13():1005692. PubMed ID: 36189292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.